Form 4: USANA Executive Brent Neidig Reports Stock Transactions
SEC Form 4 Filing
Chief Commercial Officer of USANA Health Sciences, Brent Neidig, reports transactions involving common stock and restricted stock units.
Summary
- Brent Neidig, Chief Commercial Officer of USANA Health Sciences, reported transactions on February 8, 2025.
- These transactions involved the acquisition and disposition of common stock and restricted stock units.
- Neidig acquired 1,459 shares of common stock through the vesting of restricted stock units and disposed of 648 shares to cover tax obligations at a price of $30.65.
- Additionally, Neidig acquired 3,689 shares of common stock through the vesting of restricted stock units and disposed of 1,637 shares to cover tax obligations at a price of $30.65.
- Following these transactions, Neidig directly owns 4,743 shares of common stock and 16,908 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral document, simply reporting required insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading activities.
- Companies like Herbalife Nutrition and Nu Skin Enterprises, which operate in the same industry as USANA, also require their executives to file similar reports when they trade company stock.
- The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The filing provides transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/08/2021 | Original vesting date for 25% of some Restricted Stock Units |
| 02/08/2024 | Original vesting date for 25% of some Restricted Stock Units |
| 02/08/2025 | Date of stock transactions: acquisition and disposition of common stock and restricted stock units. |
| 02/11/2025 | Date of signature for the Form 4 filing. |
Keywords
USANA, Brent Neidig, stock transactions, restricted stock units, Form 4, insider trading, Chief Commercial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.